Search by Drug Name or NDC

NDC 69102-0108-01 Roweepra 250 mg/1 Details

Roweepra 250 mg/1

Roweepra is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by OWP Pharmaceuticals, Inc.. The primary component is LEVETIRACETAM.

MedlinePlus Drug Summary

Levetiracetam is used alone and along with other medications to control partial-onset seizures (seizures that involve only one part of the brain) in adults, children, and infants 1 month of age or older. Levetiracetam is also used in combination with other medications to treat seizure in adults and children 12 years of age or older with juvenile myoclonic epilepsy. Levetiracetam is also used in combination with other medications to treat primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 6 years of age or older with epilepsy. Levetiracetam is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.

Related Packages: 69102-0108-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Levetiracetam

Product Information

NDC	69102-0108
Product ID	69102-108_14899d4b-b295-431e-b1d5-d8163bdadb87
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Roweepra
Proprietary Name Suffix	n/a
Non-Proprietary Name	Levetiracetam
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	250
Active Ingredient Units	mg/1
Substance Name	LEVETIRACETAM
Labeler Name	OWP Pharmaceuticals, Inc.
Pharmaceutical Class	Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA078858
Listing Certified Through	2024-12-31

Package

NDC 69102-0108-01 (69102010801)

Pricing Information	N/A
NDC Package Code	69102-108-01
Billing NDC	69102010801
Package	120 TABLET in 1 BOTTLE (69102-108-01)
Marketing Start Date	2020-10-28
NDC Exclude Flag	N